Evidence-based treatment of post-traumatic stress disorder

Annual Review of Medicine

Volumn 65, Issue , 2014, Pages 319-332

  Difede, Joann ^a   Olden, Megan ^a   Cukor, Judith ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Anxiety; Cognitive behavioral therapy; Fear conditioning; Stress disorders; Trauma

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; COGNITIVE THERAPY; EVIDENCE BASED PRACTICE; HEALTH SERVICE; HUMAN; INSOMNIA; LEARNING; MAJOR DEPRESSION; MEMORY CONSOLIDATION; MENTAL HEALTH; NATURAL DISASTER; NIGHTMARE; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; PSYCHOTRAUMA; REVIEW; SEROTONINERGIC SYSTEM; TERRORISM; TRAFFIC ACCIDENT; TRANSLATIONAL RESEARCH; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE; VIRTUAL REALITY EXPOSURE THERAPY;

ANTI-ANXIETY AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84901505673     PISSN: 00664219     EISSN: 1545326X     Source Type: Book Series    
DOI: 10.1146/annurev-med-051812-145438     Document Type: Review

References (87)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: Am. Psychiatr. Assoc.
2. American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: Am. Psychiatr. Assoc.
3. Breslau N. 2001. The epidemiology of posttraumatic stress disorder: What is the extent of the problem? J. Clin. Psychiatry 62:16-22 (Pubitemid 32720661)
4. Hidalgo RB, Davidson Jr. 2000. Posttraumatic stress disorder: epidemiology and health-related considerations. J. Clin. Psychiatry 61:5-13 (Pubitemid 30233559)
5. Kessler RC, Sonnega A, Bromet E, et al. 1995. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 52:1048-60
6. Yule W. 2001. Posttraumatic stress disorder in the general population and in children. J. Clin. Psychiatry 62(Suppl. 17):23-28 (Pubitemid 32720662)
7. Blanchard EB, Hickling EJ, Devineni T, et al. 2003. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav. Res. Ther. 41:79-96
8. Gradus JL, Qin P, Lincoln AK, et al. 2010. Posttraumatic stress disorder and completed suicide. Am. J. Epidemiol. 171:721-27
9. Kessler RC. 2000. Posttraumatic stress disorder: the burden to the individual and to society. J. Clin. Psychiatry 61:4-12; discussion 13-14
10. McFarlaneAC, Bookless C. 2001. The effect ofPTSDon interpersonal relationships: issues for emergency service workers. Sexual and Relationship Therapy 16:261-67
11. Friedman MJ, Schnurr PP. 1995. The relationship between trauma, post-traumatic stress disorder, and physical health. In Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to Post-Traumatic Stress Disorder, ed. MJ Friedman, D Charney, et al., pp. 507-24. Philadelphia: LippincottWilliam &Wilkins
12. Deykin EY, Keane TM, Kaloupek D, et al. 2001. Posttraumatic stress disorder and the use of health services. Psychosom. Med. 63:835-41 (Pubitemid 32911014)
13. RANDCorporation 2008. Stop loss: a nationweighs the consequences of invisible combatwounds.RAND Rev. http://www.rand.org/pubs/periodicals/rand- review/issues/summer2008/wounds2.html
14. US Office ofManagement and Budget. 2013. An economy built to last and security for military families. http://www.whitehouse.gov/omb/factsheet/an- economy-built-to-last-and-security-for-military-families
15. Hoge CW, Castro CA, Messer SC, et al. 2004. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N. Engl. J. Med. 351:13-22 (Pubitemid 38857243)
16. Woolf SH. 2008. The meaning of translational research and why it matters. JAMA 299:211-13
17. American Psychiatric Association. 2004. Practice Guideline for the Treatment of Patients with Acute Stress Disorder and Posttraumatic Stress Disorder. Arlington, VA: Am. Psychiatr. Assoc.
18. Institute ofMedicine. 2012. Treatment for Posttraumatic Stress Disorder in Military and Veteran Populations: Initial Assessment.Washington, DC: Inst. Med. (IOM)
19. Institute ofMedicine (IOM). 2008. Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence. Washington, DC: Natl. Acad. Press
20. Foa EB, Keane TM, Friedman MJ, et al., eds. 2008. Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies. New York: Guilford
21. National Institute for Clinical Excellence. 2005. Post-traumatic stress disorder (PTSD): the management of PTSD in adults and children in primary and secondary care. London: Gaskell and Br. Psychol. Soc. http://www.nice.org.uk/ nicemedia/live/10966/29769/29769.pdf
22. Steckler T, Risbrough V. 2012. Pharmacological treatment of PTSD-established and new approaches. Neuropharmacology 62:617-27
23. Management of Post-Traumatic Stress Working Group. 2010. VA/DoD clinical practice guideline for management of post-traumatic stress. Washington, DC: Dep. Veterans Aff., Dep. Defense. http://www.healthquality.va.gov/Post-Traumatic- Stress-Disorder-PTSD.asp
24. Friedman MJ, Marmar CR, Baker DG, et al. 2007. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J. Clin. Psychiatry 68:711-20 (Pubitemid 46841854)
25. HertzbergMA, FeldmanME, Beckham JC, et al. 2000. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann. Clin. Psychiatry 12:101-5 (Pubitemid 30470156)
26. Marshall RD, Lewis-Fernandez C, Blanco H, et al. 2007. A controlled trial of paroxetine for chronic PTSD, dissociation and interpersonal problems in mostly minority adults. Depress. Anxiety 24:77-84 (Pubitemid 46516663)
27. Davidson J, Baldwin D, Stein DJ, et al. 2006. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch. Gen. Psychiatry 63:1158-65 (Pubitemid 44498394)
28. Bartzokis G, Lu PH, Turner J, et al. 2005. Adjunctive risperidone in the treatment of chronic combatrelated posttraumatic stress disorder. Biol. Psychiatry 57:474-79 (Pubitemid 40311981)
29. Monnelly EP, Ciraulo DA, Knapp C, et al. 2003. Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. J. Clin. Psychopharmacol. 23:193-96 (Pubitemid 36368797)
30. Hamner MB, Faldowski RA, Ulmer HG, et al. 2003. Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int. Clin. Psychopharmacol. 18:1-8 (Pubitemid 36127054)
31. Rothbaum BO, Killeen TK, Davidson JR, et al. 2008. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry 69:520-25 (Pubitemid 351792325)
32. Vaiva G, Ducrocq F, Jezequel K, et al. 2003. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol. Psychiatry 54:947-49. Erratum Biol. Psychiatry 54:1471
33. Pitman RK, Sanders KM, Zusman RM, et al. 2002. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol. Psychiatry 51:189-92 (Pubitemid 34127909)
34. Stein MB, Kerridge C, Dimsdale JE, et al. 2007. Pharmacotherapy to prevent PTSD: results from a randomized controlled proof-of-concept trial in physically injured patients. J. Trauma. Stress 20:923-32
35. Lonergan MH, Olivera-Figueroa LA, Pitman RK, et al. 2013. Propranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysis. J. Psychiatry Neurosci. 38:222-31
36. Brunet A, Orr SP, Tremblay J, et al. 2008. Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J. Psychiatr. Res. 42:503-6 (Pubitemid 351240920)
37. Raskind MA, Peskind ER, Hoff DJ, et al. 2007. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol. Psychiatry 61:928-34 (Pubitemid 46505008)
38. Raskind MA, Peskind ER, Kanter ED, et al. 2003. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am. J. Psychiatry 160:371-73 (Pubitemid 41110467)
39. Taylor F, Martin P, Thompson C, et al. 2008. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol. Psychiatry 63:629-32 (Pubitemid 351273194)
40. Bernardy NC, Lund BC, Alexander B, et al. 2012. Prescribing trends in veterans with posttraumatic stress disorder. J. Clin. Psychiatry 73:297-303
41. Abrams TE, Lund BC, Bernardy NC, et al. 2013. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type. Psychiatr. Serv. 64:142-48
42. Belleville G, Guay S, Marchand A. 2009. Impact of sleep disturbances on PTSD symptoms and perceived health. J. Nerv. Ment. Dis. 197:126-32
43. Hembree EA, Foa EB. 2000. Posttraumatic stress disorder: psychological factors and psychosocial interventions. J. Clin. Psychiatry 61(Suppl. 7):33-39 (Pubitemid 30233562)
44. Schneier FR, Neria Y, Pavlicova M, et al. 2012. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am. J. Psychiatry 169:80-88
45. Foa EB, Davidson RT, Frances A. 1999. Expert consensus guideline series: treatment of posttraumatic stress disorder. Am. J. Clin. Psychiatry 60:5-76
46. Monson CM, Schnurr PP, Resick PA, et al. 2006. Cognitive processing therapy for veterans withmilitaryrelated posttraumatic stress disorder. J. Consult. Clin. Psychol. 74:898-907 (Pubitemid 44547484)
47. Nacasch N, Foa EB, Fostick L, et al. 2007. Prolonged exposure therapy for chronic combat-related PTSD: a case report of five veterans. CNS Spectrum 12:690-95 (Pubitemid 47571969)
48. Difede J, Malta LS, Best S, et al. 2007. A randomized controlled clinical treatment trial forWorld Trade Center attack-related PTSD in disaster workers. J. Nerv. Ment. Dis. 195:861-65
49. Gillespie K, Duffy M, Hackmann A, et al. 2002. Community based cognitive therapy in the treatment of posttraumatic stress disorder following the Omagh bomb. Behav. Res. Ther. 40:345-57 (Pubitemid 34226597)
50. Brewin CR, Scragg P, Robertson M, et al. 2008. Promotingmental health following the London bombings: a screen and treat approach. J. Trauma. Stress 21:3-8 (Pubitemid 351462813)
51. Difede J, Cukor J, Jayasinghe N, et al. 2007. Virtual reality exposure therapy for the treatment of posttraumatic stress disorder following September 11, 2001. J. Clin. Psychiatry 68:1639-47 (Pubitemid 350247492)
52. Salloum A, Overstreet S. 2008. Evaluation of individual and group grief and trauma interventions for children post disaster. J. Clin. Child Adolesc. Psychol. 37:495-507
53. Foa EB, Dancu CV, Hembree EA, et al. 1999. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J. Consult. Clin. Psychol. 67:194-200
54. Resick PA, Nishith P, Weaver TL, et al. 2002. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J. Consult. Clin. Psychol. 70:867-79
55. Foa EB, Hembree EA, Cahill SP, et al. 2005. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J. Consult. Clin. Psychol. 73:953-64 (Pubitemid 41643245)
56. Foa EB, Kozak MJ. 1986. Emotional processing of fear: exposure to corrective information. Psychol. Bull. 99:20-35
57. Difede J, Hoffman HG. 2002. Virtual reality exposure therapy for World Trade Center post-traumatic stress disorder: a case report. Cyber Psychol. Behav. 5:529-35 (Pubitemid 36055682)
58. Rizzo A, Buckwalter JG, Forbell E, et al. 2013. Virtual reality applications to address the wounds of war. Psychiatr. Ann. 43:123-38
59. Rothbaum BO, Hodges LF, Ready D, et al. 2001. Virtual reality exposure therapy for Vietnam veterans with posttraumatic stress disorder. J. Clin. Psychiatry 62:617-22 (Pubitemid 32848166)
60. Hodges LF, Anderson P, Burdea GC, et al. 2001. VR as a tool in the treatment of psychological and physical disorders. IEEE Comput. Graph. Appl. 21:25-33 (Pubitemid 33048163)
61. Reger GM, Gahm GA, Rizzo AA, et al. 2009. Soldier evaluation of the virtual reality Iraq. Telemedicine and e-Health 15:101-4
62. Karlin BE, Ruzek JI, Chard KM, et al. 2010. Dissemination of evidence-based psychological treatments for posttraumatic stress disorder in the Veterans Health Administration. J. Trauma. Stress 23:663-73
63. Nugent NR, Amstadter AB, Koenen KC. 2008. Genetics of post-traumatic stress disorder: informing clinical conceptualizations and promoting future research. Am. J. Med. Genet. C Semin. Med. Genet. 148C:127-32 (Pubitemid 351705129)
64. Soliman F, Glatt CE, Bath KG, et al. 2010. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 327:863-66
65. Ressler KJ, Rothbaum BO, Tannenbaum L, et al. 2004. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch. Gen. Psychiatry 61:1136-44 (Pubitemid 39463415)
66. Davis M, Barad M, Otto M, et al. 2006. Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches. J. Trauma. Stress 19:571-81 (Pubitemid 46424373)
67. Davis M, Ressler K, Rothbaum BO, et al. 2006. Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol. Psychiatry 60:369-75 (Pubitemid 44215855)
68. Hofmann SG, Meuret AE, Smits JAJ, et al. 2006. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch. Gen. Psychiatry 63:298-304
69. Guastella AJ, Richardson R, Lovibond PF, et al. 2008. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol. Psychiatry 63:544-49
70. Otto MW, Tolin DF, Simon NM, et al. 2010. Efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol. Psychiatry 67:365-70
71. de Kleine RA, Hendriks G-J, Kusters WJC, et al. 2012. A randomized placebo-controlled trial of Dcycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol. Psychiatry 71:962-68
72. Difede J. 2011. Enhancing exposure therapies withD-cycloserine for the treatment of chronic WTC-related PTSD. Presented at Annu. Conf. Anxiety Disord. Assoc. Am., 31st, New Orleans
73. Litz BT, Salters-Pedneault K, Steenkamp MM, et al. 2012. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J. Psychiatr. Res. 46:1184-90
74. Zimmerman JM, Maren S. 2010.NMDAreceptor antagonism in the basolateral but not central amygdala blocks the extinction of Pavlovian fear conditioning in rats. Eur. J. Neurosci. 31:1664-70
75. Walker DL, Ressler KJ, Lu K-T, et al. 2002. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J. Neurosci. 22:2343-51 (Pubitemid 35386533)
76. Ledgerwood L, Richardson R, Cranney J. 2003. Effects of D-cycloserine on extinction of conditioned freezing. Behav. Neurosci. 117:341-49 (Pubitemid 36384252)
77. van Berckel BN, Lipsch C, Gispen-de Wied C, et al. 1998. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers. Psychopharmacol. (Berl.) 138:190-97
78. Lepine JP. 2002. The epidemiology of anxiety disorders: prevalence and societal costs. J. Clin. Psychiatry. 63(Suppl. 14):4-8
79. Davidson JR, ConnorKM. 1999. Management of posttraumatic stress disorder: diagnostic and therapeutic issues. J. Clin. Psychiatry 60(Suppl. 18):33-38 (Pubitemid 29431911)
80. Blumenthal D, Causino N, Chang YC, et al. 1999. The duration of ambulatory visits to physicians. J. Fam. Pract. 48:264-71
81. Jacobsen LK, Southwick SM, Kosten TR. 2001. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am. J. Psychiatry 158:1184-90 (Pubitemid 32717688)
82. Brady KT, Killeen TK, Brewerton T, et al. 2000. Comorbidity of psychiatric disorders and posttraumatic stress disorder. J. Clin. Psychiatry 61(Suppl. 7):22-32 (Pubitemid 30233561)
83. Taylor BC, Hagel EM, Carlson KF, et al. 2012. Prevalence and costs of co-occurring traumatic brain injury with and without psychiatric disturbance and pain among Afghanistan and IraqWar Veteran V.A. users. Med. Care 50:342-46
84. Balas EA, Boren SA. 2000. Managing clinical knowledge for health care improvement. In Yearbook of Medical Informatics 2000: Patient-Centered Systems, ed. J Bemmel, AT McCray, pp. 65-70. Stuttgart, Ger.: Schattauer Verlagsgesellschaft mbH
85. Becker CB, Zayfert C, Anderson E. 2004. A survey of psychologists' attitudes towards and utilization of exposure therapy for PTSD. Behav. Res. Ther. 42:277-92
86. Feeny NC, Hembree EA, Zoellner LA. 2003. Myths regarding exposure therapy for PTSD. Cogn. Behav. Pract. 10:85-90 (Pubitemid 37087431)
87. Cahill SP, Hembree EA, Foa EB. 2006. Dissemination of prolonged exposure therapy for posttraumatic stress disorder: successes and challenges. In 9/11: Mental Health in the Wake of Terrorist Attacks, ed. Y Neria, R Gross, R Marshall, E Susser, pp. 475-95. Cambridge, UK: Cambridge Univ. Press